Highland Capital Management LLC Raises Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Highland Capital Management LLC grew its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 10.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 25,509 shares of the exchange traded fund’s stock after buying an additional 2,404 shares during the quarter. Highland Capital Management LLC’s holdings in SPDR S&P Biotech ETF were worth $2,297,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Avior Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares in the last quarter. Tidemark LLC boosted its stake in SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. purchased a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth $40,000. ORG Wealth Partners LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth $44,000. Finally, Howe & Rusling Inc. acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at about $49,000.

SPDR S&P Biotech ETF Trading Up 1.0 %

XBI opened at $93.54 on Friday. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The firm has a market capitalization of $7.13 billion, a PE ratio of 11.47 and a beta of 1.11. The firm’s 50-day moving average price is $93.31 and its 200 day moving average price is $96.77.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.